Cargando…
Aspergillus infection in chronic obstructive pulmonary diseases
Chronic obstructive pulmonary disease (COPD) is a chronic airway non‐specific inflammatory disease characterised by airway obstruction and alveolar destruction. In recent years, due to the extensive use of antibiotics, glucocorticoids, immunosuppressants and other drugs, pulmonary fungal infection i...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978918/ https://www.ncbi.nlm.nih.gov/pubmed/36710403 http://dx.doi.org/10.1111/crj.13585 |
_version_ | 1784899626678091776 |
---|---|
author | Guo, Liang Wu, Xiulin Wu, Xueling |
author_facet | Guo, Liang Wu, Xiulin Wu, Xueling |
author_sort | Guo, Liang |
collection | PubMed |
description | Chronic obstructive pulmonary disease (COPD) is a chronic airway non‐specific inflammatory disease characterised by airway obstruction and alveolar destruction. In recent years, due to the extensive use of antibiotics, glucocorticoids, immunosuppressants and other drugs, pulmonary fungal infection in patients with AECOPD, especially aspergillus infection, has gradually increased. The forms of aspergillus infection present in COPD patients include sensitisation, chronic pulmonary aspergillosis (CPA) and invasive pulmonary aspergillosis (IPA). This review will summarise diagnostic and treatment of aspergillus in COPD patients. |
format | Online Article Text |
id | pubmed-9978918 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99789182023-03-03 Aspergillus infection in chronic obstructive pulmonary diseases Guo, Liang Wu, Xiulin Wu, Xueling Clin Respir J Review Articles Chronic obstructive pulmonary disease (COPD) is a chronic airway non‐specific inflammatory disease characterised by airway obstruction and alveolar destruction. In recent years, due to the extensive use of antibiotics, glucocorticoids, immunosuppressants and other drugs, pulmonary fungal infection in patients with AECOPD, especially aspergillus infection, has gradually increased. The forms of aspergillus infection present in COPD patients include sensitisation, chronic pulmonary aspergillosis (CPA) and invasive pulmonary aspergillosis (IPA). This review will summarise diagnostic and treatment of aspergillus in COPD patients. John Wiley and Sons Inc. 2023-01-29 /pmc/articles/PMC9978918/ /pubmed/36710403 http://dx.doi.org/10.1111/crj.13585 Text en © 2023 The Authors. The Clinical Respiratory Journal published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Articles Guo, Liang Wu, Xiulin Wu, Xueling Aspergillus infection in chronic obstructive pulmonary diseases |
title | Aspergillus infection in chronic obstructive pulmonary diseases |
title_full | Aspergillus infection in chronic obstructive pulmonary diseases |
title_fullStr | Aspergillus infection in chronic obstructive pulmonary diseases |
title_full_unstemmed | Aspergillus infection in chronic obstructive pulmonary diseases |
title_short | Aspergillus infection in chronic obstructive pulmonary diseases |
title_sort | aspergillus infection in chronic obstructive pulmonary diseases |
topic | Review Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978918/ https://www.ncbi.nlm.nih.gov/pubmed/36710403 http://dx.doi.org/10.1111/crj.13585 |
work_keys_str_mv | AT guoliang aspergillusinfectioninchronicobstructivepulmonarydiseases AT wuxiulin aspergillusinfectioninchronicobstructivepulmonarydiseases AT wuxueling aspergillusinfectioninchronicobstructivepulmonarydiseases |